-
OPKO Health NASDAQ:OPK Opko Health Inc. is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies.
Location: 4400 Biscayne Blvd, Florida, 33137, US | Website: www.opko.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
1.24B
Cash
40.58M
Avg Qtr Burn
-16.8M
Short % of Float
34.70%
Insider Ownership
53.24%
Institutional Own.
27.07%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NGENLA® Somatrogon Details Pediatric growth hormone deficiency | Approved Quarterly sales | |
Rayaldee (calcifediol ER capsules) Details Chronic kidney disease | Approved Quarterly sales | |
OPK88003 (oxyntomodulin analog) (GLP-1R/GCGR agonist) Details Type 2 diabetes | Phase 2 Update | |
SAR441236 Details Human immunodeficiency virus | Phase 1 Update | |
MDX2001 (Tetraspecific LASER) Details Cancer, Solid tumor/s | Phase 1 Initiation | |
Rayaldee Details COVID-19 | Failed Discontinued |